摘要
目的分析老年ST段抬高型心肌梗死(STEMI)经皮冠状动脉介入(PCI)治疗中行替格瑞洛干预对并发症发生率的影响。方法:选取2021年8月至2022年8月期间泗洪中大医院收治的老年STEMI患者50例,按照不同治疗方法分为对照组和观察组,每组25例。对照组采用阿司匹林辅助PCI治疗,观察组采用替格瑞洛辅助PCI治疗。对比两组患者治疗前后心功能、炎症因子水平和并发症发生率。结果治疗前,两组患者的心功能、炎症因子水平对比,P>0.05;治疗后,观察组患者的心功能比对照组更好,炎症因子水平比对照组更低,P<0.05;观察组患者的并发症发生率比对照组更低,P<0.05。结论替格瑞洛可明显提高PCI治疗老年STEMI患者的心脏功能,降低炎症因子水平,减少并发症发生。
Objective:To analyze the effect of Tigrelor intervention on the incidence of complications in elderly patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention(PCI).Methods:Fifty elderly patients with ST-segment elevation myocardial infarction admitted to Sihong Zhongda Hospital from August 2021 to August 2022 were selected and divided into control group and observation group according to different treatment methods,with 25 cases in each group.The control group was treated with aspirin-assisted PCI,while the observation group was treated with Tegrelor-assisted PCI.The cardiac function,inflammatory factors and the incidence of complications were compared between the two groups before and after treatment.Results:Before treatment,the levels of cardiac function and inflammatory factors in the two groups were compared,P>0.05;After treatment,the cardiac function of patients in the observation group was better than that in the control group,and the level of inflammatory factors was lower than that in the control group,P<0.05.The incidence of complications in the observation group was lower than that in the control group,P<0.05.Conclusion:Tegrelor can significantly improve the cardiac function,reduce the level of inflammatory factors and reduce complications in elderly patients with ST-segment elevation myocardial infarction treated by PCI.
作者
季娟
Ji Juan(Cardiovascular Department of Sihong Zhongda Hospital,Sihong Jiangsu 223900,China)
出处
《生命科学仪器》
2024年第6期158-160,共3页
Life Science Instruments
关键词
老年ST段抬高型心肌梗死
经皮冠状动脉介入治疗
替格瑞洛
并发症
Elderly ST segment elevation myocardial infarction
Percutaneous coronary intervention treatment
Tigrillo
Complications
